Gene expression profiling of renal medullary carcinoma
Abstract
BACKGROUND: Renal medullary carcinoma is a rare kidney tumor with highly aggressive behavior. This tumor occurs exclusively in young patients with sickle cell trait or disease. To the authors' knowledge, very little is known to date regarding the underlying molecular genetics of this tumor, and no effective therapy has been established.METHODS: The authors analyzed the gene expression profiles of 2 renal medullary carcinomas from patients with sickle cell trait using microarrays containing 21,632 cyclic DNA (cDNA) clones and compared them with the gene expression profiles of 64 renal tumors.RESULTS: Based on global gene clustering with 3583 selected cDNAs, the authors found a distinct molecular signature of renal medullary carcinoma, which clustered closely with urothelial (transitional cell) carcinoma of the renal pelvis, rather than renal cell carcinoma (RCC). This finding of a significant difference in the gene expression patterns of renal medullary carcinoma compared with RCC suggests that this tumor should not be treated as a conventional RCC but, rather, as a special malignancy. This study also identified genes/proteins that may serve as biomarkers for renal medullary carcinoma or as potential targets of novel therapies. In addition, comparative genomic microarray analysis allowed the authors to predict the lack of chromosomal imbalances in this tumor.CONCLUSIONS: To the authors' knowledge, the current study is the first molecular profiling of renal medullary carcinoma, a rare but highly aggressive kidney carcinoma. The genes that are expressed specifically in this tumor may lead to not only a better understanding of its molecular pathways and discoveries of novel diagnostic markers but also, more important, to effective therapeutic interventions. Cancer 2004;100:976–85. © 2004 American Cancer Society.Keywords
This publication has 30 references indexed in Scilit:
- Molecular subclassification of kidney tumors and the discovery of new diagnostic markersOncogene, 2003
- Expression of α-Methylacyl-CoA Racemase (P504S) in Atypical Adenomatous Hyperplasia of the ProstateAmerican Journal of Surgical Pathology, 2002
- Inhibins/activins as diagnostic markers for ovarian cancerMolecular and Cellular Endocrinology, 2002
- Expression Profiling of Renal Epithelial NeoplasmsThe American Journal of Pathology, 2001
- Prostatic Foamy Gland Carcinoma With Aggressive BehaviorAmerican Journal of Surgical Pathology, 2001
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001
- Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and lamininCancer Letters, 2000
- Cancer as a Marker of Genetic Medical DiseaseAmerican Journal of Surgical Pathology, 1998
- R: A Language for Data Analysis and GraphicsJournal of Computational and Graphical Statistics, 1996
- Renal Medullary Carcinoma The Seventh Sickle Cell NephropathyAmerican Journal of Surgical Pathology, 1995